 | BioNT (BIONT)  |
Status
ICO
The BioNT team develops global drug pricing platform.
WhitepaperImportant By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
Ticker
BIONT
What is BioNT
The services that will be offered include: - Single global drug pricing platform - Disease and epidemiology database - Drug forecasting platform - Integrated drug pricing and forecasting system through Blockchain - Securities trading signals
Token Sale Dates
ICO
Start date: Aug 20, 2017
End date: Oct 22, 2017
Token distribution
126 million tokens available for the crowd sale campaign. 14 million tokens, with a 6 month lock up, are reserved for Advanced Intelligence GmbH and founders team. Funds allocaton: Enhancement and, Commercialization Beta Pricing Platform, 10% Development, 55% Legal, 5% Team Allocation, 10% Global Sales and Marketing, 20%
Token Price and Payment Options
Accepted Currencies ETH
Twitter
Facebook
LinkedIn
Bitcointalk
